Skip to main content

LINX® more effective than Omeprazole at controlling regurgitation and improving quality of life in patients with Gastroesophageal Reflux Disease (GERD)

Torax Medical, Inc. announced preliminary results from the CALIBER Trial that were presented at Digestive Disease Week (DDW) in Chicago, IL.  The CALIBER Trial compared LINX®, a revolutionary solution for GERD, and omeprazole, an acid suppression medication (sold under the brand name Prilosec®) to determine which treatment was more effective for managing regurgitation.

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino